Eighteen compounds, including three new triterpenoids, camellisins A-C (1-3), were isolated from the roots of Camellia sinensis. Their structures were determined on the basis of detailed spectroscopic analysis.
Regular Article
Camellia sinensis is an evergreen shrub plant of the Theaceae family. Their leaves and leaf buds are used to produce tea. Since the tea was discovered for the first time in China 1) in 2737 BC, it is at present, only next to water, the most popular beverage, and is currently grown and cultivated in at least 30 countries around the world.
2) Phytochemical and pharmacological studies of tea have provided convincing evidence that the polyphenolic antioxidants present in tea are capable of affording chemoprevention in cancer. 2, 3) Root of C. sinensis is a common traditional Chinese medicine, which has been used to cure rheumatic and hypertensive cardiopathy, coronary heart disease and arrhythmia. Previous phytochemical studies of the roots have led to the identification of some sugars, phenolic components, steroids, and triterpene saponins. 4, 5) With the aim of searching new natural compounds with interesting biological activities, we carried out phytochemical investigations on the roots of this plant collected in China. Three new triterpenoids, camellisins A-C (1-3), together with 15 known compounds have been isolated. Here, we report the structure elucidation of these new triterpenoids on the basis of their spectroscopic data and the bioassay of their cytotoxicity against five kinds of the human tumor cell lines, including HL-60, SMMC-7721, A-549, PANC-1 and SK-BR-3.
Results and Discussion
Phytochemical studies on the 70% aqueous acetone extract of the roots of C. sinensis led to the isolation of three new triterpenoids, camellisins A-C (1-3), and 15 known compounds including one triterpenoid, ursolic acid, 6) two steroids, chondrillasterol 7) and a-spinasterone, 8) six phenolic compounds, lariciresinol, 9) pinoresinol, 10) 4-O-methylcedrusin, 11) (ϩ)-balanophonin, 12) w-hydroxypropioguaiacone, 13) (E)-ferulaldehyde, 14) and six other constituents, 5-megastigmene-3,9-diol, 15) 4,5-dihydroblumen-ol A, 16) (6R,9R)-9-hydroxy-4-megastigmen-3-one, 17) blumenol B, 18 ) glycerol 1-hexadecanoate, 19) and hexadecanoic acid. 19) The known compounds were determined by comparing their mass spectra and NMR data with those of literatures. The new compounds were characterized on the basis of comprehensive spectroscopic analysis.
Camellisin A (1) was obtained as colorless needle crystals from MeOH. The high-resolution-electrospray mass spectrometry (HR-ESI-MS) exhibited a pseudo-molecular ion peak [ Fig. 1) . The heteronuclear multiple bond correlation (HMBC) spectrum displayed distinct correlations from five singlet methyl groups: from H 3 -24 (d H 1.40) to C-3, C-4, C-5; from H 3 -25 (d H 1.10) to C-1, C-5, C-9, C-10; from H 3 -26 (d H 1.09) to C-7, C-8, C-9, C-14; from H 3 -27 (d H 1.32) to C-13, C-14, C-15; and from H 3 -28 (d H 1.03) to C-16, C-17, C-18, and C-22 (Fig. 1) . The COSY correlations above and the key HMBC cross peaks built up the five rings framework as shown and assigned three of the four hydroxyls to be located at C-3 (d C 78.9), C-11 (d C 70.6), and C-21 (d C 77.7), respectively. The remained hydroxyl could only constructure an enol system with the olefinic bond of C-12 and C-13, which can be deduced by the HMBC correlations from H-9 and H-18 to C-12, H 3 -27 and H-18 to C-13, respectively (Fig. 1) Fig. 1) . Thus, the planar structure of compound 1 was established. The relative stereochemistry of 1 was ascertained by the nuclear Overhauser effects (NOEs) and X-ray diffraction. From the biosynthetic point of view, H-5 and CH 3 -27 were a-orientations, while H-18, CH 3 -25, CH 3 -26, and CH 3 -28 were b-orientations. 20) Thus, the rotating frame Overhauser enhancement (ROE) correlations of H-5 with CH 3 -23 and of H-11 with CH 3 -25 indicated both CH 3 -23 and HO-11 were a-directed. Correlations of both H-18 and CH 3 -28 with CH 3 -29 suggested that CH 3 -29 was b-orientation, while H-19 with CH 3 -30 and H-21 indicated the a-orientations of both CH 3 -30 and H-21 (Fig. 2) . The X-ray diffraction analysis of compound 1 further confirmed its relative stereochemistry (Fig.  3) . The circular dichroism (CD) spectrum of 1 showed the relatively strong p→p* transition around 208 nm for the olefin group are positive, while the weak n→p* transition 940 Vol. 58, No. 7 around 285 nm for the cyclohexanone group is negative. Analysis of the Cotton effect according to the olefin octant rule 21) and the cyclohexanone octant rule 22) indicated the rings B/C is trans while the D/E system is cis in 1. Thus, the absolute configuration of 1 was established as shown. Therefore, compound 1 was elucidated to be an ursane triterpenoid analogy, 3b, 11a, 12, 21b-tetrahydroxy-22-oxo-urs-12-en-24-oic acid, named camellisin A.
Camellisin B (2) was isolated as colorless needle crystals in MeOH. Its molecular formula, C 30 H 44 O 6 , was deduced from the positive HR-ESI-MS ion peak [MϩNa] ϩ m/z 523.3037 (Calcd 523.3036), requiring nine degrees of unsaturation. The 13 C-NMR spectrum displayed 30 carbon signals, most of which were similar to those of compound 1. The main differences were restricted to the signals of rings C and E. Among them, two oxygenated carbon signals disappeared while a carbonyl carbon one appeared. The C-9 was slightly downfield shifted ( Table 1 ) which indicated that the adjacent oxygenated C-11 in 1 was further oxygenated into the carbonyl carbon in 2. The slightly up shift of C-12 and dramatically down shift of C-13 indicated that the carbonyl carbon and the olefinic bond formed as an a,b-unsaturated ketone moiety on ring C (Table 1 ). This assumption was finally confirmed by the key HMBC correlations from H-9 to C-11 (d C 195.4) and C-12 (d C 146.6), from H-18 to C-12 and C-13 (d C 129.9), and from H 3 -27 to C-13 and C-14 (d C 45.1) (Fig. 1) .
Thus, the oxygenated methine C-21 in 1 was changed into a methylene in 2, which can be confirmed from the quaternary carbon (one oxygenated), two carbonyl groups, and one carboxyl carbon. The 1D-NMR information, together with the eight degrees of unsaturation, indicated that compound 3 was a five ring triterpenoid with three hydroxyls. Detailed comparison of its 1D-NMR data with those of compounds 1 and 2 showed that they possessed the same rings A and B. This can be further confirmed by the 1 H-1 H COSY correlations of H 2 -1/H 2 -2/H-3 and H-5/H 2 -6/H 2 -7, along with the key HMBC cross peaks of H 3 -24 with C-3 and C-5, H 3 -25 with C-1, C-5, C-9, C-10, and H 3 -26 with C-7, C-8, C-9, and C-14 (Fig. 1) . The hydroxyl at d H 7.08 (s) was assigned to be located at C-13 by the obvious HMBC correlation of d H 7.08 with C-13. The third hydroxyl group was placed at C-11, as H-9 showed obvious COSY correlation with a doublet proton at d H 5.51 (Jϭ12.1 Hz, H-11) (Fig. 1) . The distinct HMBC correlations of H-11 with d C 212.8 (s) assigned C-12 to be a carbonyl group (Fig. 1) . The 6/6 membered rings D and E were established by (Fig. 1) . The other carbonyl group was located at C-22, which can be deduced from the key HMBC correlations of d C 217.5 (s) with both H 3 -28 and H-21 (Fig.  1) .
The relative stereochemistry of 3 was established by the ROE correlations. As an oleanane triterpenoid, H-5, H-9, and CH 3 -27 were biogenetically a-orientations, while CH 3 -25, CH 3 -26, and CH 3 -28 were biogenetically b-orientations, just as those of compound 1. 20) Thus, CH 3 -24 showed ROE correlation with H-2b, H-6b, and CH 3 -26, indicated the b-orientation of CH 3 -24 and the S* configuration of C-4. H-11, presenting correlation with both CH 3 -25 and CH 3 -26, and HO-13, exhibiting correlations with H-11 and H-18, suggested that all of them were b-orientations (Fig. 4) . Thus, compound 3 was elucidated to be a new oleanane triterpenoid, 3b, 11a, 3b-trihydroxy-12,22-dioxo-olean-23-oic acid.
Compounds Fractions were monitored by TLC, and spots were visualized by spraying with 10% H 2 SO 4 in EtOH, followed by heating. Semi-preparative HPLC was performed on an Agilent 1100 liquid chromatograph with a Zorbax SB-C 18 , 9.4 mmϫ25 cm column. Melting point was obtained on an XRC-1 apparatus and was uncorrected. Optical rotations were measured on a JASCO DIP-370 digital polarimeter. CD spectra were measured on a JASCO J-810 spectropolarimeter. UV data were obtained using a UV-210A spectrometer. IR spectra were obtained on a Bio-Rad FtS-135 spectrophotometer with KBr pellets. MS were recorded on a VG Auto Spec-3000 spectrometer. NMR spectra were obtained on a Bruker DRX-400 instrument with TMS as an internal standard.
Plant Extraction and Isolation The air-dried and powdered roots (12 kg) of C. sinensis were extracted with 70% aqueous Acetone (3ϫ30 l) at room temperature to yield an extract, which was successively extracted with petroleum ether and EtOAc. The EtOAc extract was evaporated to dryness under reduced pressure to give an extract (227 g) that was separated by Si gel CC (2 kg, 100-200 mesh) and eluted with a petroleum ether/ethyl acetate gradient system (9 : 1, 8 : 2, 7 : 3, 6 : 4, 5 : 5) to give fractions 1-5. Fraction 1 (30 g), 2 (20 g) and 3 (15 g) were subjected to CC (200-300 mesh) with petroleum ether/ethyl acetate (40 : 1), petroleum ether/ethyl acetate (20 : 1), and petroleum ether/i-PrOH, respectively, affording ursolic acid (16 mg), chondrillasterol (254 mg), a-spinasterone (10 mg), glycerol 1-hexadecanoate (36 mg), and hexadecanoic acid (13 mg). Fraction 4 (10 g) was subjected to CC (200-300 mesh) with CHCl 3 /acetone (20 : 1) to afford 3 fractions, which were further purified by semipreparative HPLC (MeOH/H 2 O) to give compounds pinoresinol (62 mg), 5-megastigmene-3,9-diol (27 mg), and (6R,9R)-9-hydroxy-4-megastigmen-3-one (3 mg). 
Cytotoxicity Assay
The following human tumor cell lines were used: HL-60 (human myeloid leukemia cell line), SMMC-7721 (human hepatocarcinoma cell line), A-549 (lung cancer cell line), PANC-1 (human pancreatic carcinoma) and SK-BR-3 (breast cancer cell line). All the cells were cultured in RPMI-1640 or Dulbecco's modified Eagle's medium (DMEM) (Hyclone, Logan, UT, U.S.A.), supplemented with 10% fetal bovine serum (Hyclone, U.S.A.) at 37°C in a humidified atmosphere with 5% CO 2 . Cell viability was assessed by conducting colorimetric measurements of the amount of insoluble formazan formed in living cells based on the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) (Sigma, St. Louis, MO, U.S.A.). Briefly, 100 ml adherent cells were seeded into each well of a 96-well cell culture plate and allowed to adhere for 12 h before drug addition, while suspended cells were seeded just before drug addition, both with initial density of 1ϫ10 5 cells/ml in 100 ml medium. Each tumor cell line was exposed to the tested compound at various concentrations in triplicates for 48 h, with cis-platin (Sigma, U.S.A.) as positive control. After the incubation, MTT (100 mg) was added to each well, and the incubation continued for 4 h at 37°C. The cells were lysed with 100 ml 20% sodium dodecyl sulfate (SDS)-50% N,N-dimethylformamide (DMF) after removal of 100 ml medium. The optical density of the lysate was measured at 595 nm in a 96-well microtiter plate reader (Bio-Rad 680, U.S.A.). The IC 50 value of each compound was calculated by the Reed and Muench's method.
